Jackson Hole Capital Partners’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Jackson Hole Capital Partners’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89K	Hold	35	–	–	﹤0.01%	308
2025 Q4	$1.96K	Hold	35	–	–	﹤0.01%	304
2025 Q3	$1.68K	Buy	+35	New	+$1.56K	﹤0.01%	300

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Jackson Hole Capital Partners's XPH Position: Q1 2026 in Review

Jackson Hole Capital Partners held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q1 2026 at 35 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Jackson Hole Capital Partners first reported a position in XPH in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.96K in Q4 2025. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.

Jackson Hole Capital Partners held 35 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.89K as of Q1 2026.
Jackson Hole Capital Partners left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q1 2026.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Jackson Hole Capital Partners's portfolio in Q1 2026, its #308 holding.
Jackson Hole Capital Partners first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2025 and has held it in 3 quarters since.
Jackson Hole Capital Partners's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.96K in Q4 2025.
82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.

Based on Jackson Hole Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.